Keywords: novartis, launches, enact, program, swiss, drug, major

Novartis launches ENACT program

Article | 12 June 2006

Print This

Swiss drug major Novartis has launched the ENACT (Expanding Nilotinib Access in Clinical Trials) program, designed to improve access to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in